Skip to main content
Therapeutics and Clinical Risk Management logoLink to Therapeutics and Clinical Risk Management
. 2015 Apr 20;11:633. doi: 10.2147/TCRM.S85519

Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures [Corrigendum]

PMCID: PMC4407744  PMID: 25945054

Patel RR, Liang SY, Koolwal P, Kuhlmann FM. Therapeutics and Clinical Risk Management. 2015;11:217–228.

On page 224, Meningococcal vaccine heading, second sentence “Vaccination is recommended with the quadrivalent polysaccharide (Menactra™)” should have read “Vaccination with the quadrivalent meningococcal conjugate vaccine (MCV4) is recommended”.


Articles from Therapeutics and Clinical Risk Management are provided here courtesy of Dove Press

RESOURCES